Chlortetracycline Hydrochloride Eye Ointment
Function and Efficacy
This product is a tetracycline antibiotic. Many rickettsia, mycoplasma, chlamydia, atypical mycobacteria, and spirochetes are sensitive to this product. Enterococci are resistant to it. Due to the widespread use of tetracyclines over the years, common clinical pathogens are seriously resistant to chlortetracycline, and gram-positive bacteria such as staphylococci and most Enterobacteriaceae are resistant. There is cross-resistance between this product and different varieties of tetracyclines. The mechanism of action of this product is that the drug can specifically bind to the A position of the bacterial ribosome 30S subunit, inhibit the growth of the peptide chain and affect the synthesis of bacterial proteins.
Ingredients
Each 1g of eye ointment contains about 0.005g of chlortetracycline hydrochloride. The auxiliary materials are: liquid paraffin, white vaseline
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Chlortetracycline hydrochlorideIngredients |
This product is a tetracycline antibiotic. Many rickettsia, mycoplasma, chlamydia, atypical mycobacteria, and spirochetes are sensitive to this product. Enterococci are resistant to it. Due to the widespread use of tetracyclines over the years, common clinical pathogens are seriously resistant to chlortetracycline, and gram-positive bacteria such as staphylococci and most Enterobacteriaceae are resistant. There is cross-resistance between this product and different varieties of tetracyclines. The mechanism of action of this product is that the drug can specifically bind to the A position of the bacterial ribosome 30S subunit, inhibit the growth of the peptide chain and affect the synthesis of bacterial proteins. More |
64-72-2 | 11 | |
| PetrolatumExcipients |
This product is a tetracycline antibiotic. Many rickettsia, mycoplasma, chlamydia, atypical mycobacteria, and spirochetes are sensitive to this product. Enterococci are resistant to it. Due to the widespread use of tetracyclines over the years, common clinical pathogens are seriously resistant to chlortetracycline, and gram-positive bacteria such as staphylococci and most Enterobacteriaceae are resistant. There is cross-resistance between this product and different varieties of tetracyclines. The mechanism of action of this product is that the drug can specifically bind to the A position of the bacterial ribosome 30S subunit, inhibit the growth of the peptide chain and affect the synthesis of bacterial proteins. More |
8009-03-8 | 18 |
Appearance
This product is a yellow ointment
Indication
It is used to treat superficial ocular infections caused by sensitive Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, and sensitive Gram-negative bacteria such as Haemophilus influenzae. It can also be used to treat trachoma caused by Chlamydia trachomatis.
Usage and Dosage
Apply inside the eyelids 1 to 2 times a day.
Adverse Reactions
Rarely, blurred vision may occur after using this product. Drug-resistant strains may overgrow during use.
Precautions
Patients with a history of allergy to tetracyclines are contraindicated.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Not yet clear
Storage
Store tightly closed in a dry, cool place.
Packaging Specification
0.5%
Validity Period
48 months.
Manufacturer
Three Pharmaceutical Drug Group (Wuhu) Co., Ltd.
-
Founded in:
2005-11-10 -
Address:
China (Anhui) Pilot Free Trade Zone Wuhu Area Jiuhua North Road Biopharmaceutical Technology Park -
Tax NO.:
91340207781090474X -
Registered Funds:
15 million yuan -
Website:
-
Email: